Gpi Spa · MIL:GPI
Gpi Spa — Mid & Small Milan 2023
19 slides from Gpi Spa's conference presentation, Nov 23, 2023
Slide 1: Mid & Small | Milan
Mid & Small | Milan 23 11 2023
Slide 2: Vision, Mission, Values
2 VISION VALUES to be at the forefront of the technological ETHICS RESPONSIBILITY and sustainable transformation of preventive and care processes for PEOPLE-CENTERED PASSION healthcare, promoting the well-being of CARE individuals. MISSION we strive to provide health professionals and patients with
Slide 3: The Transformative Power of Digital Health Solutions
3 The Transformative Power of Digital Health Solutions Current environment Digital health solution Effects and streamlining Resources optimization and Shortage of medical staff AUTOMATION impact on average (doctors, nurses) hospitalization Complex and intricate Process facilitation and MANAGEMENT SO
Slide 4: FY22 Revenue and EBITDA
4 FY22 Revenue EBITDA € 360.2 M € 54.2 M 1988 - 35 years of experience, History of management team with an Steady Growth excellent track record of internal % on adj. Revenue (1) growth and effective M&As 16.7% 16.4% 16.0% 360 solutions and products used by 327 15.2% 15.1% International 3,000 + clien
Slide 5: Executive Summary H1 23
5 Executive Summary H1 23 Revenue € 193 M, EBITDA € 26 M H1 23 showed a double-digit increase in revenue (+14 %) coupled with a strong EBITDA growth (+50%) stemming from the favorable SBAs’ mix In August, Gpi successfully completed its most important and transformational acquisition of the French Gr
Slide 6: Business Highlights
6 Business New International Contracts: Highlights 2023 Eastern EU: QCare Intensive Care Unit & QCare Anesthesia 18 hospitals | 930 workplaces ~ € 5 M Automation: Canary Is., Germany, Switzerland, Hungary, Sweden, China and Japan ~ € 6 M New contracts in USA, Spain ~ € 2 M Framework Agreements updat
Slide 7: Half-year Economic Results H1 23
7 Half-year Economic Results H1 23 STRONG IMPROVEMENT IN REVENUE AND PROFITABILITY as an effect of the shift to Technologically-driven SBAs. Revenue H1 23 - H1 22 EBITDA H1 23 - H1 22 +14% +50% 14.4% % EBITDA on adj. Revenue 13.5% % on tot. Revenue 11.0% 10.2% 9.7% 10.3% 193 9.3% 8.9% 169 152 26 117
Slide 8: Outstanding Results of the Technological Business Areas
8 Outstanding Results of the Technological Business Areas Boosting on EBITDA 2.9% 19.7% 24.0% 0.9% 2.6% % EBITDA 19.6% 23.9% 0.8% on adj. Revenue 87.6 81.8 83.1 on tot. Revenue 57.7 Revenue 19.5 EBITDA 11.3 2.3 0.7 H1 22 H1 23 H1 22 H1 23 Software Care 11.9% 23.1% 6.6% 31.2% 19.9% 26.7% 10.1 10.8 9.
Slide 9: Revenue and EBITDA by Business Area
9 Revenue The shift to technologically-driven SBAs EBITDA resulted in an improvement in profitability for the entire Group. 13% 34% H1 22 Software: 10% 52% € 169 M Revenue up by an impressive + 42%, driven by organic H1 22 4% € 17 M (19.3%) and inorganic (22.5%) growth. EBITDA Boost: achieved an out
Slide 10: Geographic Footprint H1 23
10 Geographic Footprint H1 23 Italy: the entire offering Europe & RoW: Blood, HIS, LIS, Automation RoW +68% H1 o H1 Export 13.8% Italy Italy 86.2% % of worldwide revenue H1 23 Freepik
Slide 11: Guidance 2023
11 Guidance 2023 Significant contribution from value-accretive M&As Revenue 2023 PF EBITDA 2023 PF € ~460 M € ~88 M 460 88 360 327 54 271 50 40 Net Financial Debt in compliance with the financial covenants. 2020A 2021A 2022A 2023E 2020A 2021A 2022A 2023E Pro Forma1 Pro Forma1 Note: (1) pro forma inc
Slide 12: Investment Quick Take and Shareholder Structure
12 Investment Quick Take Shareholder structure based on information available to Gpi on November 16th, 2023 Leadership and Uniqueness GPI IN THE STOCK MARKET FM (Manzana Family) ISIN: IT0005221517 34.2% CDP Equity Ticker: GPI:IM 47.0% Treasury Shares Growth and Visibility Price 20 November 2023 € 8.
Slide 13: Takeaways
13 Takeaways • STRATEGIC for the Healthcare Systems • SOLID GROWTH in both Revenue and EBITDA • SOUND and CLEAR STRATEGY • NATIONAL and EUROPEAN REFERENCE POINT Innovation for Sustainable Healthcare Via Ragazzi del '99, 13 - 38123 Trento | T +39 0461 381515 | investor.relations@gpi.it
Slide 14: Appendix Financial Statements
Appendix Financial Statements
Slide 15: Consolidated Income Statement
15 CONSOLIDATED INCOME STATEMENT ‘000 Euros H1 2023 H1 2022 Revenue 189,833 167,470 Other income 3,062 1,445 Total revenue and other income 192,895 168,914 Raw materials and consumables (9,058) (5,445) Service costs (48,045) (45,962) Personnel expense (107,955) (98,510) Amortisation, depreciation an
Slide 16: Consolidated Balance Sheet
16 CONSOLIDATED BALANCE SHEET ‘000 Euros 30 June 2023 31 December 2022 Assets Goodwill 124,947 125,235 Other intangible assets 89,825 86,767 Property, plant and equipment 40,704 34,484 Equity-accounted investments 308 111 Non-current financial assets 11,401 11,580 Deferred tax assets 11,134 9,140 Co
Slide 17: Shareholders' Equity and Liabilities
17 Shareholders’ equity Share capital 13,890 13,890 Share premium reserve 209,562 209,562 Other reserves and retained earnings/(losses carried forward), including 11,824 25,451 profit/(loss) for the period Capital and reserves attributable to owners of the parent 235,276 248,903 Capital and reserves
Slide 18: Consolidated Cash Flow Statement
18 CONSOLIDATED CASH FLOW STATEMENT ‘000 Euros H1 2023 H1 2022 Cash flows from operating activities Profit for the period 506 250 Adjustments for: – Depreciation of property, plant and equipment 4,424 3,232 – Amortisation of intangible assets 10,231 7,654 – Amortisation of contract costs 290 1,247 –
Slide 19: Disclaimer
19 Disclaimer The material in this presentation was prepared by GPI S.p.A. ("GPI” or the “Company”) without any paragraph 2, letters a) to d) of the Order; and (C) other persons to whom this presentation can be form of independent verification; it is general, basic information about the current busi